presentation by Anton Aulbers, Senior Consultant 3D Pharma printing at TNO
What drives you?
What drives me is realizing valid solutions to real world problems. I am an engaged team player and I like to analyze complex problems, split them up in clear steps and identify surprising and creative solutions which can be implemented by and with partners.
Why should the delegate attend your presentation?
The possibilities for the combination of Personalized Medicine and 3D printing are exciting but still have a long way to go. Everybody in the field who is interested and wants to know more about the TNO state of the art is invited to take part in this journey.
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
In the short run 3D Pharma printing can speed up the process of pharma R&D. In the long run as personalized diagnostics further develop it has the potential to enable truly personalized drug delivery.
What kind of impact do you expect them to have?
The impact of 3D Pharma printing can be on several levels. For companies: Faster development and production of drug dosage forms for ever smaller target groups. For consumers: Personalized treatment based upon individual health related data. For society: Better health and a more effective and cost efficient health system.
What are the barriers that might stand in the way?
Barriers that have to be solved will be technological as well as logistical or regulatory.
I strongly believe that when you start working on it in the right place and with the right partners the hurdles can be solved along the way, building from a minimum viable product towards full system innovation.
Personalized Medicine is the future, 3D printing is part of the way to get there!
Anton Aulbers has a background in Industrial Design Engineering. He has 30 years of experience in co-creating innovative multi-disciplinary technical solutions for and with customers in a wide range of domains, such as 3D printing. He has been responsible for projects in the field of Equipment and Process development for Additive Manufacturing within TNO for the past 10 years. As Senior Consultant 3D Pharma printing Anton is taking the lead in tracking developments globally, defining the TNO roadmap for digital drug manufacturing, building strategic partnerships and developing the technology towards implementation in the market.
TNO is an independent research organisation that connects people and knowledge to create innovations that boost the competitive strength of industry and the well-being of society in a sustainable way. Innovation with purpose is what TNO stands for. We develop knowledge not for its own sake, but for practical application. TNO has been developing Additive Manufacturing expertise for more than 30 years. The Food & Pharma Printing Expertise Group is ready to put that expertise to work for you.
3D Pharma Printing Conference (February 4, 2021) addresses the latest developments in 3D printing medicines, as 3D printing is expected to find a place in certain niche medications and in personalised tablets. The topics approached include: New formulations for improved drug delivery; Patient-centric design / personalised medicine; Local manufacture / Simplified logistics; Faster pre-clinical evaluation of new drugs; Regulation & certification.
Anton is speaker at the 2021 edition of the conference.